Back
Adaptive Biotechnologies Stock Price Chart
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!
Sell
34
ADPT
Adaptive Biotechnologies
Last Price:
2.75
Seasonality Move:
1.15%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).- The current trend is relatively stagnant and ADPT is experiencing selling pressure, which indicates risk of future bearish movement.
Adaptive Biotechnologies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.51 | Buy |
| 20-day SMA: | 2.69 | Sell |
| 50-day SMA: | 3.25 | Sell |
| 200-day SMA: | 4.74 | Sell |
| 8-day EMA: | 2.59 | Buy |
| 20-day EMA: | 2.73 | Sell |
| 50-day EMA: | 3.14 | Sell |
| 200-day EMA: | 4.69 | Sell |
Adaptive Biotechnologies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 42.59 | Sell |
| Chaikin Money Flow: | -505204 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.52 - 3.02) | Sell |
| Bollinger Bands (100): | (3.04 - 4.6) | Sell |
Adaptive Biotechnologies Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptive Biotechnologies Stock
Is Adaptive Biotechnologies Stock a Buy?
- Adaptive Biotechnologies share price is 2.60 while ADPT 8-day simple moving average is 2.51, which is a Buy signal.
- The stock price of ADPT is 2.60 while Adaptive Biotechnologies 20-day SMA is 2.69, which makes it a Sell.
- Adaptive Biotechnologies 50-day simple moving average is 3.25 while ADPT share price is 2.60, making it a Sell technically.
- ADPT stock price is 2.60 and Adaptive Biotechnologies 200-day simple moving average is 4.74, creating a Sell signal.
ADPT Technical Analysis vs Fundamental Analysis
Sell
34
Adaptive Biotechnologies (ADPT)
is a Sell
Is Adaptive Biotechnologies a Buy or a Sell?
-
Adaptive Biotechnologies stock is rated a Sell
The current Adaptive Biotechnologies [ADPT] share price is $2.60. The Score for ADPT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Adaptive Biotechnologies Stock Info
Market Cap:
377.24M
Price in USD:
2.60
Share Volume:
1.07M
Adaptive Biotechnologies 52-Week Range
52-Week High:
9.08
52-Week Low:
2.28
Sell
34
Adaptive Biotechnologies (ADPT)
is a Sell
Adaptive Biotechnologies Share Price Forecast
-
What is the Adaptive Biotechnologies stock price today?
The Adaptive Biotechnologies stock price is 2.60 USD today. -
Will ADPT stock go up or go down?
Adaptive Biotechnologies> share price is forecast to RISE/FALL based on technical indicators -
Is Adaptive Biotechnologies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptive Biotechnologies is overvalued.
Is Adaptive Biotechnologies Stock a Buy?
- Adaptive Biotechnologies share price is 2.60 while ADPT 8-day exponential moving average is 2.59, which is a Buy signal.
- The stock price of ADPT is 2.60 while Adaptive Biotechnologies 20-day EMA is 2.73, which makes it a Sell.
- Adaptive Biotechnologies 50-day exponential moving average is 3.14 while ADPT share price is 2.60, making it a Sell technically.
- ADPT stock price is 2.60 and Adaptive Biotechnologies 200-day simple moving average is 4.69, creating a Sell signal.
Fundamental Analysis of Adaptive Biotechnologies
Is Adaptive Biotechnologies a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.02 per share, an increase this year of $0.11 per share, and an increase next year of $0.30 per share.
Technical Analysis of Adaptive Biotechnologies
Should I short Adaptive Biotechnologies stock?
- ADPT Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Adaptive Biotechnologies is a Sell
- Adaptive Biotechnologies Relative Strength Index (RSI) is 42.59, which suggest Adaptive Biotechnologies is oversold
- The Bollinger Bands (25) for Adaptive Biotechnologies is (2.52 - 3.02), which suggest Adaptive Biotechnologies is a Sell
- The Bollinger Bands (100) for Adaptive Biotechnologies is (3.04 - 4.6), which suggest Adaptive Biotechnologies is a Sell
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.